Blog

This is tagline here

Begbroke Science Park > News and Press > Imperial College London and CN Bio Innovations Ltd present new advances in the pre-clinical evaluation of Hepatitis B therapies
Please set your featured image

Imperial College London and CN Bio Innovations Ltd present new advances in the pre-clinical evaluation of Hepatitis B therapies

CN Bio Innovations Ltd Logo

Begbroke Science Park tenant CN Bio Innovations Ltd (CN Bio), an expert in developing human biomimetic platforms to test and develop therapeutics for serious diseases, has announced that data from its research collaboration with Imperial College London, where the team are analysing a novel human, full-viral-lifecycle model of Hepatitis B, will be the subject of oral and poster presentations at three international meetings this Autumn, including:

Download Full Press Release PDF

Joanna Grant